Using X-ray images and deep learning for automated detection of coronavirus disease

Abstract

Coronavirus is still the leading cause of death worldwide. There are a set number of COVID-19 test units accessible in emergency clinics because of the expanding cases daily. Therefore, it is important to implement an automatic detection and classification system as a speedy elective finding choice to forestall COVID-19 spreading among individuals. Medical images analysis is one of the most promising research areas, it provides facilities for diagnosis and making decisions of a number of diseases such as Coronavirus. This paper conducts a comparative study of the use of the recent deep learning models (VGG16, VGG19, DenseNet201, Inception_ResNet_V2, Inception_V3, Resnet50, and MobileNet_V2) to deal with detection and classification of coronavirus pneumonia. The experiments were conducted using chest X-ray & CT dataset of 6087 images (2780 images of bacterial pneumonia, 1493 of coronavirus, 231 of Covid19, and 1583 normal) and confusion matrices are used to evaluate model performances. Results found out that the use of inception_Resnet_V2 and Densnet201 provide better results compared to other models used in this work (92.18% accuracy for Inception-ResNetV2 and 88.09% accuracy for Densnet201). ARTICLE HISTORY

Application of deep learning techniques for detection of COVID-19 cases using chest X-ray images: A comprehensive study

“…To date, more than five million people across the globe have been infected, and there are approximately three lakhs confirmed death cases as reported by the World Health Organization (WHO) [1] . It is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the common symptoms of COVID-19 include fever, myalgia, dry cough, headache, sore throat, and chest pain [2] , [3] and therefore, it is considered as a respiratory disease. It can take around 14 days to show complete symptoms in the infected person.…”

Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19

“…Therefore, Nsp15 is considered critical in coronavirus biology. Detection technique(s) also remains a critical factor for treatment and may still need improvements Elasnaoui & Chawki, 2020). There is no existing vaccine or proven drug for this disease, but various treatment options such as utilizing medicines effective in other viral ailments, are being attempted against SARS-COV2 (Babadaei, Hasan, Vahdani, et al, 2020;Elmezayen et al, 2020;Khan, Jha, Amera, et al, 2020;Mahanta et al, 2020;Muralidharan et al, 2020).…”

Natural compounds fromClerodendrumspp. as possible therapeutic candidates against SARS-CoV-2: Anin silicoinvestigation

“…The catastrophic coronavirus disease 2019 (COVID-19) pandemic caused by a novel coronavirus referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has brought the world to a standstill and has afflicted global public health (Abraham et al, 2020;Bhardwaj et al, 2020;Elasnaoui & Chawki, 2020;Paniri et al, 2020;. The virus has infected over six million people and has ruthlessly claimed nearly four hundred thousand lives till date (as per updates on June 2, 2020) (https://www.worldometers.…”